DiaSorin (OTCMKTS:DSRLF) Shares Gap Up – Should You Buy?

DiaSorin S.p.A. (OTCMKTS:DSRLFGet Free Report) shares gapped up before the market opened on Tuesday . The stock had previously closed at $68.33, but opened at $74.34. DiaSorin shares last traded at $74.34, with a volume of 300 shares trading hands.

Wall Street Analyst Weigh In

Separately, Morgan Stanley raised DiaSorin from an “underweight” rating to an “overweight” rating in a report on Tuesday, August 26th. Two investment analysts have rated the stock with a Buy rating, According to MarketBeat, DiaSorin presently has a consensus rating of “Buy”.

Read Our Latest Research Report on DiaSorin

DiaSorin Trading Up 7.0%

The stock’s fifty day simple moving average is $80.22 and its 200 day simple moving average is $95.41.

DiaSorin Company Profile

(Get Free Report)

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.

Read More

Receive News & Ratings for DiaSorin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DiaSorin and related companies with MarketBeat.com's FREE daily email newsletter.